Malaysian mRNA vaccine against Covid-19 under development, says Adham

PUTRAJAYA (Bernama): Malaysia is developing a vaccine to protect against Covid-19 using the messenger ribonucleic acid (mRNA) technology.

The Malaysian Institute for Medical Research (IMR) started developing it with Universiti Putra Malaysia (UPM) in November 2020, said Health Minister Datuk Seri Dr Adham Baba at a joint press conference with National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin today.

“The original SARS-CoV-2 virus and its variants are now in the cloning stage,” he said about the current status of vaccine development.

He said that the process includes testing in small and big animals (in the pre-clinical stage), then three phases of clinical trials in humans, before the vaccine can be registered and mass-produced.

With regard to healthcare workers reinfected with the virus after two vaccine shots, Adham said there were 1,480 cases with a single category 4 case suffering from pneumonia and requiring respiratory support.

He said that the majority of cases were in categories 1 or 2, and suffered no symptoms or symptoms sans pneumonia.

“This shows that the vaccines protect people against serious symptoms. The data also shows its effectiveness in healthcare workers,” he said.

Adham said that genomic surveillance efforts had identified 183 Covid-19 variants, with 167 being variants of concern (VOC) and 16 variants of interest (VOI).

“Therefore, surveillance will continue for the next three months,” he said.



Referenced on 22.6.2021



Previous Post

Govt studying to shorten AstraZeneca dose interval, says Dr. Adham

Next Post

Sepsis: What Is Sepsis?

Related Posts